If you could find out if you and your children were genetically predisposed to developing Alzheimer’s or dementia, would you want to know? What would you do with that information?”
The U.S.-based company 23andme has been up and down on the popularity charts.
YAY! They’ve offering genetic testing.
BOO! The test could convince you to take unnecessary, unhealthy actions.
YAY! Cheap genetic testing now available in United Kingdom.
In the middle of Google-backed 23andme‘s early rise as media darling, FastCo. reporter Elizabeth Murphy talked about the ethics of getting the DNA picture of your child, say. In a story titled INSIDE 23ANDME FOUNDER ANNE WOJCICKI’S $99 DNA REVOLUTION:
“There’s something scary about asking for cold, hard, computer-driven data about someone you love. Did I really want to know? What would I do with the information? Would I change as a parent if I found out she was at risk for something scary, and would that change be helpful or harmful to her?” (Oct. 2013)
The DNA ancestry test, or Personal Genome Service, is $199 in Canada; the FDA banned the test in the U.S. on Nov. 24, 2013, citing “false positive or false negative results that could prompt patients to get unnecessary surgery,” according to Reuters.
But many with Alzheimer’s in their family really, really want to know. NEXT
About the author